Press release
Global Adalimumab Biosimilar Market Data Survey Report 2025
Get sample copy of the report:
www.marketdensity.com/contact?ref=Sample&reportid=7403
Table of Contents:
1 Adalimumab Biosimilar Market Overview
1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Classification of Adalimumab Biosimilar by Product Category
1.2.1 Global Adalimumab Biosimilar Market Size (Sales) Comparison by Type
1.2.2 Global Adalimumab Biosimilar Market Size (Sales) Market Share by Type (Product Category)
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Global Adalimumab Biosimilar Market by Application/End Users
1.3.1 Global Adalimumab Biosimilar Sales (Volume) and Market Share Comparison by Application
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Adalimumab Biosimilar Market by Region
1.4.1 Global Adalimumab Biosimilar Market Size (Value) Comparison by Region
1.4.2 United States Adalimumab Biosimilar Status and Prospect
1.4.3 China Adalimumab Biosimilar Status and Prospect
1.4.4 Europe Adalimumab Biosimilar Status and Prospect
1.4.5 Japan Adalimumab Biosimilar Status and Prospect
1.4.6 Southeast Asia Adalimumab Biosimilar Status and Prospect
1.4.7 India Adalimumab Biosimilar Status and Prospect
1.5 Global Market Size (Value and Volume) of Adalimumab Biosimilar
1.5.1 Global Adalimumab Biosimilar Sales and Growth Rate
1.5.2 Global Adalimumab Biosimilar Revenue and Growth Rate
2 Global Adalimumab Biosimilar Competition by Players/Suppliers, Type and Application
2.1 Global Adalimumab Biosimilar Market Competition by Players/Suppliers
2.1.1 Global Adalimumab Biosimilar Sales and Market Share of Key Players/Suppliers
2.1.2 Global Adalimumab Biosimilar Revenue and Share by Players/Suppliers
2.2 Global Adalimumab Biosimilar (Volume and Value) by Type
2.2.1 Global Adalimumab Biosimilar Sales and Market Share by Type
2.2.2 Global Adalimumab Biosimilar Revenue and Market Share by Type
2.3 Global Adalimumab Biosimilar (Volume and Value) by Region
2.3.1 Global Adalimumab Biosimilar Sales and Market Share by Region
2.3.2 Global Adalimumab Biosimilar Revenue and Market Share by Region
2.4 Global Adalimumab Biosimilar (Volume) by Application
3 United States Adalimumab Biosimilar (Volume, Value and Sales Price)
3.1 United States Adalimumab Biosimilar Sales and Value
3.1.1 United States Adalimumab Biosimilar Sales and Growth Rate
3.1.2 United States Adalimumab Biosimilar Revenue and Growth Rate
3.1.3 United States Adalimumab Biosimilar Sales Price Trend
3.2 United States Adalimumab Biosimilar Sales Volume and Market Share by Players
3.3 United States Adalimumab Biosimilar Sales Volume and Market Share by Type
3.4 United States Adalimumab Biosimilar Sales Volume and Market Share by Application
4 China Adalimumab Biosimilar (Volume, Value and Sales Price)
4.1 China Adalimumab Biosimilar Sales and Value
4.1.1 China Adalimumab Biosimilar Sales and Growth Rate
4.1.2 China Adalimumab Biosimilar Revenue and Growth Rate
4.1.3 China Adalimumab Biosimilar Sales Price Trend
4.2 China Adalimumab Biosimilar Sales Volume and Market Share by Players
4.3 China Adalimumab Biosimilar Sales Volume and Market Share by Type
4.4 China Adalimumab Biosimilar Sales Volume and Market Share by Application
5 Europe Adalimumab Biosimilar (Volume, Value and Sales Price)
5.1 Europe Adalimumab Biosimilar Sales and Value
5.1.1 Europe Adalimumab Biosimilar Sales and Growth Rate
5.1.2 Europe Adalimumab Biosimilar Revenue and Growth Rate
5.1.3 Europe Adalimumab Biosimilar Sales Price Trend
5.2 Europe Adalimumab Biosimilar Sales Volume and Market Share by Players
5.3 Europe Adalimumab Biosimilar Sales Volume and Market Share by Type
5.4 Europe Adalimumab Biosimilar Sales Volume and Market Share by Application
6 Japan Adalimumab Biosimilar (Volume, Value and Sales Price)
6.1 Japan Adalimumab Biosimilar Sales and Value
6.1.1 Japan Adalimumab Biosimilar Sales and Growth Rate
6.1.2 Japan Adalimumab Biosimilar Revenue and Growth Rate
6.1.3 Japan Adalimumab Biosimilar Sales Price Trend
6.2 Japan Adalimumab Biosimilar Sales Volume and Market Share by Players
6.3 Japan Adalimumab Biosimilar Sales Volume and Market Share by Type
6.4 Japan Adalimumab Biosimilar Sales Volume and Market Share by Application
7 Southeast Asia Adalimumab Biosimilar (Volume, Value and Sales Price)
7.1 Southeast Asia Adalimumab Biosimilar Sales and Value
7.1.1 Southeast Asia Adalimumab Biosimilar Sales and Growth Rate
7.1.2 Southeast Asia Adalimumab Biosimilar Revenue and Growth Rate
7.1.3 Southeast Asia Adalimumab Biosimilar Sales Price Trend
7.2 Southeast Asia Adalimumab Biosimilar Sales Volume and Market Share by Players
7.3 Southeast Asia Adalimumab Biosimilar Sales Volume and Market Share by Type
7.4 Southeast Asia Adalimumab Biosimilar Sales Volume and Market Share by Application
8 India Adalimumab Biosimilar (Volume, Value and Sales Price)
8.1 India Adalimumab Biosimilar Sales and Value
8.1.1 India Adalimumab Biosimilar Sales and Growth Rate
8.1.2 India Adalimumab Biosimilar Revenue and Growth Rate
8.1.3 India Adalimumab Biosimilar Sales Price Trend
8.2 India Adalimumab Biosimilar Sales Volume and Market Share by Players
8.3 India Adalimumab Biosimilar Sales Volume and Market Share by Type
8.4 India Adalimumab Biosimilar Sales Volume and Market Share by Application
9 Global Adalimumab Biosimilar Players/Suppliers Profiles and Sales Data
9.1 AET BioTech
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Adalimumab Biosimilar Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.1.4 Main Business/Business Overview
9.2 Amgen
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Adalimumab Biosimilar Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.2.4 Main Business/Business Overview
9.3 Boehringer Ingelheim
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Adalimumab Biosimilar Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.3.4 Main Business/Business Overview
9.4 Coherus Biosciences
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Adalimumab Biosimilar Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.4.4 Main Business/Business Overview
9.5 Fujifilm Kyowa Kirin Biologics
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Adalimumab Biosimilar Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.5.4 Main Business/Business Overview
9.6 LG Life Sciences/Mochida Pharmaceutical
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Adalimumab Biosimilar Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.6.4 Main Business/Business Overview
9.7 Momenta Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Adalimumab Biosimilar Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.7.4 Main Business/Business Overview
9.8 Oncobiologics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Adalimumab Biosimilar Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.8.4 Main Business/Business Overview
9.9 Pfizer
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Adalimumab Biosimilar Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.9.4 Main Business/Business Overview
9.10 Samsung Bioepsis
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Adalimumab Biosimilar Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin
9.10.4 Main Business/Business Overview
9.11 Sandoz
9.12 Zydus Cadila
10 Adalimumab Biosimilar Manufacturing Cost Analysis
10.1 Adalimumab Biosimilar Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Adalimumab Biosimilar
10.3 Manufacturing Process Analysis of Adalimumab Biosimilar
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Adalimumab Biosimilar Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Adalimumab Biosimilar Market Forecast
14.1 Global Adalimumab Biosimilar Sales Volume, Revenue and Price Forecast
14.1.1 Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast
14.1.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast
14.1.3 Global Adalimumab Biosimilar Price and Trend Forecast
14.2 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast by Region
14.2.1 Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast by Regions
14.2.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast by Regions
14.2.3 United States Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast
14.2.4 China Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast
14.2.5 Europe Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast
14.2.6 Japan Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast
14.2.7 Southeast Asia Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast
14.2.8 India Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast
14.3 Global Adalimumab Biosimilar Sales Volume, Revenue and Price Forecast by Type
14.3.1 Global Adalimumab Biosimilar Sales Forecast by Type
14.3.2 Global Adalimumab Biosimilar Revenue Forecast by Type
14.3.3 Global Adalimumab Biosimilar Price Forecast by Type
14.4 Global Adalimumab Biosimilar Sales Volume Forecast by Application
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
Buy this report online:
www.marketdensity.com/global-adalimumab-biosimilar-market-data-survey-report-2025
About Market Density:
Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
Email: sales@marketdensity.com
Website: www.marketdensity.com
Phone: +1 669 264 1656
4340 Stevens Creek Blvd,
Suite # 172,
San Jose, CA 95129
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Adalimumab Biosimilar Market Data Survey Report 2025 here
News-ID: 1639766 • Views: …
More Releases from Market Density
Global Product Management Software Market Size, Status and Forecast
This report focuses on the global Product Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Product Management Software development in United States, Europe and China. In 2017, the global Product Management Software market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players…
Global Computer Aided Engineering (CAE) Market Size, Status and Forecast
This report focuses on the global Computer Aided Engineering (CAE) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computer Aided Engineering (CAE) development in United States, Europe and China. Computer-aided engineering is the broad usage of computer software to aid in engineering analysis tasks. In regard to information networks, CAE systems are individually considered a single node on a total information…
Global Computerized Numerical Control Market Size, Status and Forecast
This report focuses on the global Computerized Numerical Control status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computerized Numerical Control development in United States, Europe and China. Computer numerical control (CNC) is the automation of machine tools by means of computers executing pre-programmed sequences of machine control commands. The key factor contributing to the computerized numerical control market is the growth…
Global Connected Retail Market Size, Status and Forecast
This report focuses on the global Connected Retail status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Connected Retail development in United States, Europe and China. A Connected Retail strategy allows people to use the strength of the network to connect the brands to today's consumers. Connected Retail can help collaborate more effectively with employees and field managers, maintain security vigilance and…
More Releases for Adalimumab
Adalimumab Biosimilar Market Report and Forecast 2024-2032
Global Adalimumab Biosimilar Market Outlook
The adalimumab biosimilar market is expected to grow at a CAGR of about 17.60% in the forecast period of 2024-2032, driven by the rising incidence of rheumatoid arthritis, especially amongst the rapidly growing geriatric population.
Adalimumab Biosimilar: Introduction
Adalimumab biosimilars are biologic medical products highly similar to the reference product, Humira, which is used to treat autoimmune diseases. These biosimilars offer comparable efficacy, safety, and quality at a…
Adalimumab Biosimilar Market Size, Share, Trends 2024-2032
The adalimumab biosimilar market is witnessing substantial growth, driven by the rising incidence of rheumatoid arthritis and an increasing geriatric population. Adalimumab, a popular biologic for treating various inflammatory diseases, has seen a surge in biosimilar counterparts due to their cost-effectiveness and expanding applications. The market is expected to grow at a CAGR of about 17.60% from 2024-2032, reflecting significant opportunities for industry players.
Get a Free Sample Report with Table…
Adalimumab Market Insights, Forecast to 2031
"Adalimumab Market 2024,"
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Adalimumab market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Adalimumab industry, providing stakeholders with a nuanced perspective on market dynamics.
Furthermore, the…
Adalimumab Market Size, Status & Forecast 2024
Global Adalimumab Market: Overview
Adalimumab, with a trade name of Humira and Exemptia, is an anti-TNF drug used for treating rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and ulcerative colitis. Adalimumab usually binds with tumor necrosis factor-alpha (TNFα). When a TNFα binds to a TBFα receptors, it results in an inflammatory response to autoimmune disease. Adalimumab, by binding to a TNFα, lowers the chances of inflammatory response.
View Report @ http://www.transparencymarketresearch.com/adalimumab-market.html
Adalimumab, which…
Adalimumab Market - Forecasts from 2014 to 2020
Adalimumab is a biologic TNF inhibiting anti-inflammatory medication which is a patented medicine of Abbott Biotechnology Ltd. Jochen G. Salfeld et al invented the product and trade names for the product are Exemptia and Humira. Humira stands for "human monoclonal antibody in rheumatoid arthritis". Humira targets and acts as building block for TNF-alpha production, and lowering inflammation. TNF blockers with HUMIRA, has adverse affects on the immune system which…
Increasing Research and Penetration of Adalimumab Biosimilars Boosts Demand for …
The impending patent expiration has resulted in the sluggish growth rate of the adalimumab market in Latin America. The entry of biosimilars has further aggravated the market’s concerns. Transparency Market Research (TMR) pegs the valuation of the Latin America adalimumab market at US$994.8 mn in 2014. Expanding at a weak CAGR of 0.4% from 2015 to 2023, the market is forecast to reach US$1,186.4 mn by the end of 2023.
Download…
